CAD (NASDAQ:ICAD) (market cap: $85.26M), a leader in AI-powered breast cancer detection, reported its third-quarter 2024 financial results, demonstrating a 4% year-over-year increase in revenue to $4.

CAD (ICAD) is advancing 5% in early trading despite today’s sharp downturn of the broader market. The company, whose products utilize AI to detect breast cancer, preannounced higher-than-expected ...

iCAD expects total revenue for the fourth quarter of 2024 to be between approximately $5.1 and $5.3 million. Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer ...

Dana Brown, Chief Executive Officer, and Eric Lonnqvist, Chief Financial Officer, of iCAD will participate in one-on-one meetings with investors at the event. To request a meeting with iCAD ...

On January 27, 2025, iCAD, Inc. (NASDAQ: ICAD) disclosed certain preliminary, unaudited financial information for the fourth quarter ending on December 31, 2024, alongside additional corporate ...

CAD to Participate in the BTIG at Snowbird:12th Annual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASHUA, N.H., Jan.